UiPath Stock Forecast, Price & News

-0.25 (-0.36 %)
(As of 06/18/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
Volume3.18 million shs
Average Volume3.08 million shs
Market Capitalization$36.21 billion
P/E RatioN/A
Dividend YieldN/A
30 days | 90 days | 365 days | Advanced Chart
Receive PATH News and Ratings via Email

Sign-up to receive the latest news and ratings for UiPath and its competitors with MarketBeat's FREE daily newsletter.

UiPath logo

About UiPath

UiPath Inc. provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, and Japan. It develops UiPath Studio, a platform designed for RPA developers looking to build complex process automations with built-in governance capabilities, such as robust debugging tools, application programming interface automation, wizards to automate desktop or web applications, leverage custom code, and to integrate machine learning models into production workflows. The company also offers UiPath Robots, which emulates human behavior to execute the processes built in UiPath Studio; and UiPath Orchestrator that tracks and logs robot activity, along with what people do in tandem to maintain strict compliance and governance through dashboards and visualization tools. In addition, it provides maintenance and support for its software, as well as professional services, such as training and implementation services to facilitate the adoption of its platform. UiPath Inc. was founded in 2005 and is headquartered in New York, New York.


See More Headlines

Industry, Sector and Symbol

Sales & Book Value






Overall MarketRank

1.10 out of 5 stars

Business Services Sector

238th out of 505 stocks

Prepackaged Software Industry

171st out of 311 stocks

Analyst Opinion: 3.2Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

UiPath (NASDAQ:PATH) Frequently Asked Questions

Is UiPath a buy right now?

19 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for UiPath in the last twelve months. There are currently 11 hold ratings and 8 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" UiPath stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in PATH, but not buy additional shares or sell existing shares.
View analyst ratings for UiPath
or view top-rated stocks.

What stocks does MarketBeat like better than UiPath?

Wall Street analysts have given UiPath a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but UiPath wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How were UiPath's earnings last quarter?

UiPath Inc. (NASDAQ:PATH) posted its quarterly earnings results on Monday, June, 7th. The healthcare company reported $0.02 EPS for the quarter, topping the Zacks' consensus estimate of ($0.05) by $0.07.
View UiPath's earnings history

How has UiPath's stock price been impacted by Coronavirus?

UiPath's stock was trading at $18.00 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, PATH shares have increased by 287.5% and is now trading at $69.75.
View which stocks have been most impacted by COVID-19

What guidance has UiPath issued on next quarter's earnings?

UiPath updated its second quarter 2022 earnings guidance on Tuesday, June, 15th. The company provided earnings per share (EPS) guidance of $- for the period. The company issued revenue guidance of $180 million-185 million.

What price target have analysts set for PATH?

19 equities research analysts have issued 12-month price objectives for UiPath's stock. Their forecasts range from $64.00 to $86.00. On average, they anticipate UiPath's share price to reach $76.89 in the next twelve months. This suggests a possible upside of 10.2% from the stock's current price.
View analysts' price targets for UiPath
or view top-rated stocks among Wall Street analysts.

Who are UiPath's key executives?

UiPath's management team includes the following people:
  • Mr. Daniel Solomon Dines, Co-Founder, CEO, & Chairman (Age 49)
  • Mr. Marius Tirca, Co-Founder & CTO
  • Mr. Ashim Gupta, Chief Financial Officer (Age 42)
  • Mr. Eddie O'Brien, Sr. VP of Operations & Partners
  • Mr. Mihai Faur, Corp. Controller & Chief Accounting Officer
  • Mr. Brad C. Brubaker, Gen. Counsel, Chief Legal Officer & Sec. (Age 57)
  • Mr. Robert B. Patrick, Chief Marketing Officer (Age 49)
  • Mr. Christopher Townsend, VP of Federal Sales
  • Mr. Vijay Khanna, Chief Corp. Devel. Officer
  • Ms. Bettina H. Koblick, Chief People Officer (Age 55)

Who are some of UiPath's key competitors?

What other stocks do shareholders of UiPath own?

When did UiPath IPO?

(PATH) raised $990 million in an initial public offering on Wednesday, April 21st 2021. The company issued 21,300,000 shares at a price of $43.00-$50.00 per share. Morgan Stanley, JPMorgan, BofA Securities, Credit Suisse, Barclays and Wells Fargo Securities acted as the underwriters for the IPO and SMBC Nikko, BMO Capital Markets, Mizuho Securities USA, KeyBanc Capital Markets, TD Securities (USA), Truist SecuritiesCowen, Evercore Group, Macquarie Capital (USA), Nomura, RBC Capital Markets, Canaccord Genuity, D. A. Davidson & Co., Oppenheimer & Co. and Needham & Co. were co-managers.

What is UiPath's stock symbol?

UiPath trades on the NASDAQ under the ticker symbol "PATH."

When did UiPath's quiet period expire?

UiPath's quiet period expired on Monday, May 31st. UiPath had issued 23,890,777 shares in its public offering on April 21st. The total size of the offering was $1,337,883,512 based on an initial share price of $56.00. During UiPath's quiet period, insiders and any underwriters involved in the IPO were restricted from issuing any research reports for the company because of regulations issued by the Securities and Exchange Commission. Now that the company's quiet period has ended, brokerages that served as underwriters are now able to initiate research on the company.

How do I buy shares of UiPath?

Shares of PATH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is UiPath's stock price today?

One share of PATH stock can currently be purchased for approximately $69.75.

How much money does UiPath make?

UiPath has a market capitalization of $36.21 billion.

How many employees does UiPath have?

UiPath employs 2,863 workers across the globe.

What is UiPath's official website?

The official website for UiPath is

Where are UiPath's headquarters?

UiPath is headquartered at 7 Great Valley Pkwy Ste 300, MALVERN, PA 19355-1425, United States.

How can I contact UiPath?

UiPath's mailing address is 7 Great Valley Pkwy Ste 300, MALVERN, PA 19355-1425, United States. The healthcare company can be reached via phone at +1-610-2320800 or via email at [email protected]

This page was last updated on 6/20/2021 by Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.